Biogen Pharma, a company in the Other Financial Services industry, reported revenue of ₹0.28 crore and net profit of ₹0.26 crore for the September 2026 quarter.
Biogen Pharma (BSE: BIOGEN) closed at ₹0.29 on 20 Nov 2026, down 56.7% over the past year. Its market capitalisation is ₹31 crore and it trades at 52.7 times earnings.
Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading in shares and securities.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.